Position in INCY
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$7,368
+$1,533 QoQ
Shares Held
65
+4.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#766
of 854 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HIGHLINE WEALTH PARTNERS LLC holds $984,033 across 14 Biotechnology names. INCY ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,739 | $863,813 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
1,000 | $54,540 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20 | $12,470 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
48 | $11,566 | |
| 5 | EXEL |
Exelixis, Inc.
|
201 | $10,936 | |
| 6 | TECH |
BIO-TECHNE Corp
|
128 | $9,043 | |
| 7 | INCY |
Incyte Corp
This page
|
65 | $7,368 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
18 | $5,418 |
All Filings in INCY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,368 | 65 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $5,835 | 62 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $592 | 6 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $508 | 6 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $408 | 6 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $363 | 6 | Shares | Sole | 2025-04-17 | |
| No filing history on record for this holder in this stock. | ||||||